About John Harper
Form D filings for Triopsy Medical from 2020 to 2024 list John Harper as director.
John Harper first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name John Harper in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people John Harper works with at each company, as listed on that company's latest Form D.
Triopsy Medical, Inc. · Form D, Feb 28, 2024
RL
Richard Larson
Director
DB
David Bostwick
Executive officer and director
JL
James Lousararian
Director
Brad Buscher
Executive Chairman
DW
Deborah Wittman
Director
MM
Michael Montag
Director